Welcome Guest
Sign In
Register
Products
Popular Categories
Antibody Search
ELISA Kit Search
Biomolecules
Flow Cytometers
Thermal Cyclers
Microscopes
Transfection Reagents
Featured Products
New Products
Research Areas
ELISA
Western Blot
3D Cell Culture
Digital PCR
Quantitative PCR
Cell and Gene Therapy
In Vivo Models
Resources
eBooks
Bench Tips
Tech Insights
Editorial Articles
News
Product Reviews
Future Lab
White Papers
Infographics
Events
Promotions
Multimedia
Biocompare Webinars
Technologies Transforming Precision Medicine
Immunotherapy
Reproducibility
Transformative Technologies
Podcasts
Bench Tip Videos
All Videos and Webinars
Life Science Webinars
Write a Review
Antibodies
Kits/Reagents
Equipment
Services
Register
Sign In
Biocompare
Products
Cell Biology
Biomolecules
Biomolecules
Recombinant SIV p27 (mac239) [His]
Recombinant SIV p27 (mac239) [His] from Creative Diagnostics
Be the first to write a review!
Citations:
(1)
Supplier Page
Supplier Page from
Creative Diagnostics for
Recombinant SIV p27 (mac239) [His]
Description
C-terminal 6xHis tagged HIV-1/clade A p27 protein
Product Specs
Company Info
Citations
Reviews
Product Specs
Item
Recombinant SIV p27 (mac239) [His]
Company
Creative Diagnostics
Price
Supplier Page
View Company Product Page
Catalog Number
DAG2381
Source/Expression System
E. coli
Type
Recombinant
Purity
≥ 95%
Format
Liquid
Conjugate/Tag
His
Concentration
1 mg/ml
Applications
WB, ELISA
Add to Compare List
Creative Diagnostics
Phone
: 1-631-624-4882 (USA)
44-161-818-6441 (Europe)
Email: info@creative-diagnostics.com
Company Profile
Website:
https://www.creative-diagnostics.com/
Citations (1)
(1)
Efficient treatment and pre-exposure prophylaxis in rhesus macaques by an HIV fusion-inhibitory lipopeptide
Cell
January 6, 2022
Xue J, Chong H, Zhu Y, Zhang J, Tong L, Lu J, Chen T, Cong Z, Wei Q, He Y.
<<
<
>
>>
Reviews
Be the First to Write a Review!
Recombinant SIV p27 (mac239) [His] from Creative Diagnostics
Supplier Page
View Company Product Page
Product Specs
Company Info
Citations
Reviews
Back To Top